Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

NCT00389935

Conditions: Angiodysplasia, Arteriovenous Malformation, Arteriovenous Malformations, +21 more
Locations: Medical College of Georgia Augusta, Georgia, United States

UMass Memorial Medical Center Worcester, Massachusetts, United States

Northport VAMC Northport, New York, United States

View Trial Details

Completed

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma

NCT00263484

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Tata Memorial Hospital Mumbai, India

Christian Medical College Vellore, Tamil Nadu, India

Singapore General Hospital Singapore

National Cancer Centre, Singapore Singapore

View Trial Details

Completed

Oral Vitamin K for Warfarin Associated Coagulopathy

NCT00143715

Conditions: Bleeding, Cardiovascular Diseases, Coagulation, +10 more
Locations: Kaiser Permanente of Colorado Clinical Pharmacy Westminster, Colorado, United States

University of New Mexico Health Sciences Center Albuquerque, New Mexico, United States

Queen Elizabeth II Health Health Sciences Halifax, Nova Scotia, Canada

Hamilton General Hospital Hamilton, Ontario, Canada

View all 15 locations

View Trial Details

Completed

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00089037

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

A Multiple Myeloma Trial in Patients With Bone Metastases

NCT00104104

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hematology Oncology Specialists Huntsville, Alabama, United States

Palo Verde Hematology Oncology Glendale, Arizona, United States

US Oncology Tucson, Arizona, United States

Myeloma Institute For Research Therapy Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Completed

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

NCT00546780

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Comprehensive Blood And Cancer Center Bakersfield, California, United States

Moores Ucsd Cancer Center La Jolla, California, United States

University Of California Medical Center San Francisco, California, United States

Rocky Mountain Cancer Centers Denver, Colorado, United States

View all 19 locations

View Trial Details

Completed

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

NCT00165295

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia

NCT00142129

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

NCT00142155

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00003146

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions